Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 49-64 of 94
- NeuroFrontiers
Keys to Closing the Gender Gap in Stroke Trials
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Cheryl Carcel, MD, PhD
- NeuroFrontiers
Diagnosing Mental Illness with the Perspectives Approach
Charles Turck, PharmD, BCPS, BCCCP
Margaret Chisolm, MD
- NeuroFrontiers
What to Know About Post-COVID-19 Neurological Syndrome
Jerome Lisk, MD
Tissa Wijeratne MD PhD FRACP FRCP FAAN
- NeuroFrontiers
Could T Cells Lead to New MS Treatments?
Jerome Lisk, MD
Shivashankar Othy, DVM, PhD
- NeuroFrontiers
Emerging Treatments for Traumatic Brain Injury, Including Virtual Reality & Therapeutic Ultrasound
Rita Hitching MSc
Maheen Mausoof Adamson, PhD
Andrew Wilner, MD, FACP, FAAN
Maheen Mausoof Adamson, PhD
Andrew Wilner, MD, FACP, FAAN
Ken Paller, PhD
Andrew Wilner, MD, FACP, FAAN
Bret Stetka, MD
Andrew Wilner, MD, FACP, FAAN
Jerome Lisk, MD
Ilan Wittstein, MD
- NeuroFrontiers
Investigating Impulses: A Look at Deep Brain Stimulation
Jerome Lisk, MD
Jerrold Vitek, MD, PhD
Jerome Lisk, MD
Jerrold Vitek, MD, PhD
David Weisman, MD
Adil Javed, MD PhD
- NeuroFrontiers
Expanding on the Neurologic Effects of COVID-19
Andrew Wilner, MD, FACP, FAAN
Jennifer A. Frontera, MD